Daphne Karydas MBA
President and Chief Financial Officer at Flare Therapeutics Inc., a privately held biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
Daphne brings over 20 years of leadership experience in the biopharmaceutical and asset management sectors to the Compass board. Before joining Flare Therapeutics in October 2021, she served as Chief Financial Officer and Treasurer of Syndax Pharmaceuticals, Inc., and held roles including Senior Vice President of Corporate Financial Planning & Analysis and Strategy at Allergan plc, until its acquisition by AbbVie in May 2020. Earlier in her career, she built a strong foundation in financial and strategy roles, including healthcare analyst positions at JPMorgan Asset Management, The Boston Company Asset Management, and Goldman Sachs Asset Management, and as a Vice President in the healthcare group of the investment banking division at Goldman, Sachs & Co. Her experience also includes prior service as a board member of several public companies.
She is an MIT graduate in chemical engineering and holds an MBA from Harvard Business School.